Skip to content
+1 (800) 559-9921
MRM Proteomics
  • Shop
    • Kits
      • MetaboloMetrics™ Kits
      • PeptiQuant™ Plus Kits
        • Human Plasma
        • Mouse Plasma
        • Quality Control
    • Request a Quote
  • About Us
    • Company
    • Technology
  • Services
    • Service Portfolio
    • Clinical Diagnostics
    • Metabolomics
    • PeptiQuant™ Protein Quantitation
    • Protein Characterization
    • Tissue Imaging
  • Bioinformatics
  • Products
    • MetaboloMetrics™ Kits
      • Amino Acids
      • Bile Acids
    • PeptiQuant™ Plus Kits
      • Protein Quantitation
      • Quality Control
    • PeptiCov
    • SysQuan
  • QuaProLIMS
  • Workshops
  • News
    • News
    • Events
    • Publications
  • Contact
    • MRMP Europe

The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application

Share:

Facebook
Twitter
Google+
LinkedIn
Pinterest

Post navigation

Previous PostMultiplexed Dilute-and-Shoot Liquid Chromatography-Multiple-Reaction Monitoring Mass Spectrometry Clinical Assay for Metanephrines and Catecholamines in Human Urine
Next PostCharacterization of 53 Multiplexed Targeted Proteomics Assays for Verification Studies in Cancer Cell Lines
YasseneMohammed

Written by Yassene Mohammed

What are you looking for?

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

CONTACT

MRM Proteomics Inc.
SB-5100
141, Ave du Président-Kennedy
Montreal, QC, H2X 1Y4 Canada

Tel: +1 (800) 559-9921
Email: info@mrmproteomics.com
URL: www.mrmproteomics.com

QUICK LINKS

Company Technology Services Products News Contact

GENERAL

Terms and Conditions Shipping FAQ Privacy Policy Terms of Use Resources Calendar of Events
2019 © MRM Proteomics. All Rights Reserved | Privacy Policy